NCT03750305

Brief Summary

This study explores the effectiveness of a brief Imagery-focussed Cognitive Therapy (imCT) compared to psychoeducation, regarded as treatment as usual for this patient population, in patients suffering from BD receiving mood stabilising medication. ImCT was successfully tested in a pilot study using a case series design. The investigators now elaborate on this study comparing effectiveness of the intervention to psychoeducation/TAU.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

October 1, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 23, 2018

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

August 31, 2021

Status Verified

August 1, 2021

Enrollment Period

2.2 years

First QC Date

February 27, 2018

Last Update Submit

August 30, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline Mood variability to follow up at 16 weeks after end of intervention

    Mood variability is measured using the Affect Lability Score Short Version (ALS-18; Oliver \& Simons, 2004). The ALS-18 is a self-report scale measuring lability in affect and consists of 18 items. Ratings are made on a 4-point scale with a maximum score of 72. Scores range from A= very characteristic of me (4 points), to D= very uncharacteristic of me (1 point).

    The ALS-18 is administered at T0, after 4 weeks baseline at T1, after the end of intervention (12 weeks in the ImCT condition, and 6 weeks in the psychoeducation condition) T2, 8 weeks after the end of intervention T3, and after 16 weeks follow up -T4.

Secondary Outcomes (7)

  • Change from baseline Level of depression to follow up at to follow up at 16 weeks

    measured weekly throughout the duration of the study in both groups (32 weeks imCT and 26 weeks psychoeducation/TAU).

  • Change from baseline level of mania to follow up at 16 weeks

    measured weekly throughout the duration of the study in both groups ( 32 weeks imCT and 26 weekspsychoeducation/TAU).

  • Change from baseline level of anxiety to follow up at 16 weeks

    measured both daily and weekly throughout the duration of the study in both groups (32 weeks imCT and 26 weeks psychoeducation/TAU)

  • Change from baseline level of hopelessness to follow up at 16 weeks follow up

    measured at baseline (T0), after 4 weeks pre-intervention (T1), post-intervention after 6 weeks in the psychoeduc condition and 12 weeks in the ImCT condition (T2) and at follow up at 8 weeks (T3) and at 16 weeks (T4).

  • Change from baseline level of general functioning and coping to follow up at 16 weeks

    Participants rate their level of functioning at baseline (T0), after 4 weeks pre-intervention (T1), post-intervention12 weeks in the ImCT condition and 6 weeks in the psychoeducation condition (T2) and at follow up at 8 weeks (T3) and at 16 weeks (T4).

  • +2 more secondary outcomes

Other Outcomes (3)

  • General Imagery (frequency of imagery, quality of imagery and appraisals of imagery):

    administered at T0, after 4 weeks baseline at T1, after the end of intervention (12 weeks in the ImCT condition, and 6 weeks in the psychoeducation condition) T2, 8 weeks after the end of intervention T3, and after 16 weeks follow up -T4.

  • Ratings of target imagery (moderator)

    Measured weekly throughout the study for 32 weeks in the ImCT condition and 26 weeks in the psychoeducation condition

  • General Imagery

    administered at T0, after 4 weeks baseline at T1, after the end of intervention (12 weeks in the ImCT condition, and 6 weeks in the psychoeducation condition) T2, 8 weeks after the end of intervention T3, and after 16 weeks follow up -T4.

Study Arms (2)

psychoeducation/TAU

ACTIVE COMPARATOR

TAU consists of psycho-education for a period of 12 weeks, consisting of 6 2-hour sessions. Psycho-education is offered in groups,

Other: TAU

imCT intervention

EXPERIMENTAL

For a period of 12 weeks, 12 1-hour sessions of imagery-focused Cognitive Therapy delivered weekly by a trained therapists, divided in an in depth identification (4 sessions) of images followed by imagery interventions, (6 sessions) and a consolidation phase (2 sessions).

Other: imagery-focused Cognitive Therapy

Interventions

In depth identification phase: Therapists and patient collaboratively map out difficulties and pinpoint a treatment focus. Imagery interventions: The imagery intervention consists of metacognitive imagery rescripting or promoting positive imagery or competing tasks (or a combination of these). Consolidation: Consist of fine tuning the strategies, relapse prevention using a video diary.

Also known as: ImCT
imCT intervention
TAUOTHER

Psycho-education is offered in groups, using the format described by Honig (Postma, Honig, \& van Gent, 2008).

Also known as: Psychoeducation
psychoeducation/TAU

Eligibility Criteria

Age18 Years - 68 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18-68
  • Sufficient Dutch language ability to permit the assessment to be completed.
  • Diagnosis of DB (I or II or NOS) according to DSM-5 (clinicians assessment).
  • Willing to complete daily and weekly monitoring throughout the duration of the study.
  • Successful completion of the daily monitoring in the 4 weeks active run-in phase.
  • Willing to be randomised to either imCT or psychoeducation/TAU condition
  • Can commit to attending 12 consecutive weekly sessions imCT or psychoeducation/TAU.

You may not qualify if:

  • Learning difficulties, organic brain disease or severe neurological impairment.
  • Current severe substance or alcohol misuse (clinicians assessment).
  • Current manic episode as diagnosed by DSM-5
  • Current active psychotic symptoms
  • Presence of active suicidal risk as indicated by a score of 2 or more on item 12 (i.e. frequent thought and/or plans to end their life) of the QIDS (Rush et al., 2003) confirmed by convergent clinical opinion.
  • Taking part in concurrent treatment studies investigating pharmacological or psychological treatment for BD.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centrum Bipolair, GGzE

Eindhoven, Netherlands

Location

Related Publications (1)

  • van den Berg KC, Hendrickson AT, Hales SA, Voncken M, Keijsers GPJ. Comparing the effectiveness of imagery focussed cognitive therapy to group psychoeducation for patients with bipolar disorder: A randomised trial. J Affect Disord. 2023 Jan 1;320:691-700. doi: 10.1016/j.jad.2022.09.160. Epub 2022 Oct 5.

Related Links

MeSH Terms

Conditions

Bipolar Disorder

Condition Hierarchy (Ancestors)

Bipolar and Related DisordersMood DisordersMental Disorders

Study Officials

  • karin van den Berg

    Maastricht University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Between groups, comparing Imagery-Focussed therapy with psychoeducation/TAU/within group, comparing baseline phase with treatment phase.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Psychologist, PhD student Maastricht University

Study Record Dates

First Submitted

February 27, 2018

First Posted

November 23, 2018

Study Start

October 1, 2018

Primary Completion

December 30, 2020

Study Completion

December 30, 2020

Last Updated

August 31, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations